Insider Transactions by Atlas Venture Opportunity Fund II, L.P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerMar 01, 2024Sale$30.0529,435884,5221,458,691Mar 05, 2024, 05:07 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerMar 01, 2024Sale$30.0517,099513,825847,388Mar 05, 2024, 05:07 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 28, 2024Sale$24.84154,6743,841,5765,700,521Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 28, 2024Sale$24.8436,246900,2281,488,486Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 26, 2024Sale$23.72201,0954,769,0966,216,250Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 26, 2024Sale$23.7247,1241,117,5771,564,932Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 27, 2024Sale$24.41298,7027,290,0885,878,544Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 27, 2024Sale$24.4169,9971,708,3381,514,874Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 23, 2024Sale$22.7037,386848,6621,585,137Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 21, 2024Sale$22.57184,5014,164,8176,666,628Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 22, 2024Sale$22.66119,3602,704,6986,512,104Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerFeb 23, 2024Sale$22.70159,5423,621,6046,352,562Feb 23, 2024, 06:58 PM
IRONDisc Medicine, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerJan 23, 2024Sale$67.6547,5003,213,3751,402,186Jan 25, 2024, 04:31 PM
IRONDisc Medicine, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerJan 23, 2024Sale$67.65102,5006,934,125703,660Jan 25, 2024, 04:31 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerDec 12, 2022Buy$10.70934,58110,000,017934,581Dec 14, 2022, 04:55 PM
DAWNDay One Biopharmaceuticals, Inc.Atlas Venture Opportunity Fund II, L.P.10% OwnerJun 17, 2022Buy$15.00766,66711,500,005766,667Jun 22, 2022, 05:09 PM